Deep Lens Brochure - Thumbnail- 251 px
Deep Lens for Clinical Trials


Speeding patients to trials

By identifying patients at the time of diagnosis, our advanced AI-enabled patient recruitment platform compresses study timelines by finding the best-suited patients for clinical trials

Molecular Testing for Treatment of Metastatic Non-Small Cell LungCancer

The recent discovery of relevant biomarkers has reshaped our approach to therapy selection for patients with non-small cell lung cancer. The unprecedented outcomes demonstrated with tyrosine kinase inhibitors in molecularly defined cohorts of patients has underscored the importance of genetic profiling in this disease.

Deep Lens White Papers
Critical Aspects of a Sustainable Clinical Recruitment Trial

Increasing enrollment into clinical trials is a top priority across the field of oncology. Because the vast majority of those afflicted with cancer receive their care in the community, creating strong clinical research programs in the community-based setting is important. This article comprehensively outlines the most important elements of creating and sustaining a successful community-based research program.


Our website contains links to websites owned and operated by third parties. If you use these links, you leave our website. These links are provided for your information and convenience only and are not an endorsement by Deep Lens of the content of such linked websites or third parties. Deep Lens has no control over the contents of any linked website and is not responsible for these websites or their content or availability.